Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Studies in Lung Cancer: Independent Conference Coverage of the World Conference on Lung Cancer 2020

Shirish M. Gadgeel, MD
Nicolas Girard, MD, PhD
Released: March 31, 2021
Back Next

Introduction

Key Studies on Lung Cancer and Other Thoracic Malignancies

At the 2020 World Conference on Lung Cancer (WCLC) annual meeting, new clinical trial data on lung cancers and other thoracic malignancies were reported, including novel approaches in non-small-cell lung cancer (NSCLC), small-cell lung cancer (SCLC), and mesothelioma. In this module, Shirish M. Gadgeel, MD, and Nicolas Girard, MD, PhD, review and discuss the clinical implications of key studies in these thoracic malignancies that were presented at the meeting.

Please note that the slide thumbnails in this activity link to a PowerPoint highlights slideset that can also be found here, which contains summaries of key studies presented at the 2020 WCLC virtual meeting that were selected by the experts. This slideset may also be downloaded by clicking on any of the thumbnails within the activity.

Clinical Care Options plans to measure the educational impact of this activity. A few questions will be asked twice: once at the beginning of the activity and then once again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.

Back Next
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Amgen
Bristol-Myers Squibb
Ipsen Biopharmaceuticals, Inc.
Janssen Pharmaceutica NV
Jazz Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme
Takeda Oncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings